CapsoVision (NASDAQ:CV) Major Shareholder Eliyahou Et Al Harari Acquires 61,068 Shares

CapsoVision, Inc. (NASDAQ:CV) major shareholder Eliyahou Et Al Harari purchased 61,068 shares of CapsoVision stock in a transaction that occurred on Friday, July 17th. The shares were purchased at an average cost of $6.73 per share, with a total value of $410,987.64. Following the transaction, the insider directly owned 3,343,119 shares of the company’s stock, valued at $22,499,190.87. This represents a 1.86% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Eliyahou Et Al Harari also recently made the following trade(s):

• On Wednesday, July 8th, Eliyahou Et Al Harari acquired 81,300 shares of CapsoVision stock. The stock was purchased at an average price of $6.09 per share, with a total value of $495,117.00.
• On Friday, June 26th, Eliyahou Et Al Harari bought 13,850 shares of CapsoVision stock. The shares were acquired at an average price of $7.35 per share, for a total transaction of $101,797.50.

CapsoVision Trading Up 0.2%

CapsoVision stock opened at $6.62 on Wednesday. CapsoVision, Inc. has a 12 month low of $3.43 and a 12 month high of $15.37. The stock has a fifty day simple moving average of $6.78 and a two-hundred day simple moving average of $6.28. The firm has a market cap of $330.74 million and a price-to-earnings ratio of -2.83.

CapsoVision (NASDAQ:CV) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.15) earnings per share (EPS) for the quarter. The firm had revenue of $2.79 million during the quarter.

Institutional Investors Weigh In On CapsoVision

A number of large investors have recently added to or reduced their stakes in the stock. Deutsche Bank AG bought a new position in shares of CapsoVision during the 4th quarter valued at $47,000. Wells Fargo & Company MN grew its holdings in shares of CapsoVision by 66.4% in the fourth quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock worth $67,000 after acquiring an additional 2,508 shares during the period. Citadel Advisors LLC bought a new stake in shares of CapsoVision in the third quarter worth $115,000. Virtu Financial LLC purchased a new stake in CapsoVision during the fourth quarter valued at $128,000. Finally, Bank of America Corp DE increased its position in CapsoVision by 528.9% during the first quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock valued at $162,000 after acquiring an additional 18,702 shares during the last quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of CapsoVision in a research note on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $8.50.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.